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induces invasive phenotype in colon cancer
cells through overexpression of MMP-7
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Background: Although matrix metalloproteinase (MMP)-7 expression is correlated with increased metastatic
potential in human colon cancer cells, the underlying molecular mechanism of invasive phenotype remains
unknown. In the current study, we investigated the regulatory effects of membrane NADPH oxidase (NOX) and
AMP activated protein kinase (AMPK) on MMP-7 expression and invasive phenotype change in colon cancer cells.
Methods: Production of superoxide anion was measured by lucigenin chemiluminescence assay using whole cells
and protein extracts (NADPH oxidase activity), and intracellular reactive oxygen species (ROS) by fluorescence
microscopy using 2’,7’-dichlorofluorescein diacetate (DCF-DA). Quantitative real-time polymerase chain reaction
(qRT-PCR) and Western blotting were used to measure mRNA and protein levels, respectively. siRNA transfection
was used to assess involvement of genes in cancer invasion, which were identified by Matrigel transwell invasion
assay. Luciferase reporter assay was performed to identify transcription factors linked to gene expression.
Results: Under basal conditions, less invasive human colon cancer cells (HT29 and Caco-2) showed low MMP-7
expression but high NOX1 expression and AMPK phosphorylation. Treatment of HT29 and Caco-2 cells with
12-O-tetradecanoylphorbol-13-acetate (TPA) induced an invasive phenotype response along with corresponding
increases in ROS production and NOX2 and MMP-7 expression as well as reduced AMPK phosphorylation, which
resemble basal conditions of highly invasive human colon cancer cells (SW620 and HCT116). In addition, inverse
regulation between AMPK phosphorylation and NOX2 and MMP-7 expression was observed in HT29 cells treated
with different concentrations of exogenous hydrogen peroxide. TPA-induced invasive phenotype in HT29 cells was
abolished by treatment with Vit. E, DPI, apocynin, and NOX2 siRNA but not NOX1 siRNA, indicating NOX2-derived
ROS production induced an invasive phenotype. TPA-induced induction of MMP-7 expression was suppressed by
AP-1, NF-κB, and MAPK (ERK, p38, and JNK) inhibitors, whereas TPA-induced expression of NOX2 and its regulators,
p47phox and p67phox, was blocked by p38 and NF-κB inhibitors.
Conclusions: Molecular switch from NOX1 to NOX2 in colon cancer cells induces ROS production and
subsequently enhances MMP-7 expression by deactivating AMPK, which otherwise inhibits stimulus-induced
autoregulation of ROS and NOX2 gene expression.
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Colorectal cancer is the third most common cancer
worldwide [1], and metastasis is the major cause of can-
cer mortality. Small invasive cells at the advancing edge
of tumors are recognized as an independent prognostic
factor for colorectal cancer [2]. Increasing evidence has* Correspondence: jakim@yu.ac.kr
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creativecommons.org/publicdomain/zero/1.0/established a link between overexpression of matrix metal-
loproteinases (MMPs), which play critical roles in cancer
cell invasion and metastasis by degrading the extracellular
matrix, and cancer stage and/or prognosis [3]. In the case
of colorectal carcinomas, MMP-7 overexpression is corre-
lated with increased invasion and metastasis. Therefore,
MMP-7 overexpression is recognized as an independent
marker of colorectal cancer progression [4–10].article distributed under the terms of the Creative Commons Attribution License
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dent on activator protein 1 (AP-1), which is a transcrip-
tion factor that binds to the promoter region of MMP-7
[11–13]. In addition, MMP-7 expression via JNK/AP-1
pathway activation has been recently observed in cultured
cells treated with exogenous H2O2 [14, 15]. Compared to
normal cells, cancer cells produce large amounts of re-
active oxygen species (ROS) [16], which are involved in
multiple signaling cascades related to carcinogenesis, in-
cluding invasion and migration of cancer cells [17–20].
During the transition to a malignant phenotype, ROS are
known to activate mitogen-activated protein kinases
(MAPKs), including the ERK, JNK, and p38 pathways,
leading to expression of MMPs for tumor invasion and
metastasis [21–23]. ROS are produced not only as by-
products of energy metabolism in mitochondria and the
cytosol but also as signaling messengers upon activation
of various cell membrane receptors for growth factors
[24, 25], cytokines [26], and integrin [27] via membrane
NADPH oxidase (NOX). Alteration of MMP expression
by NOX1-generated ROS has been studied in various
types of cells, including K-Ras-transformed normal rat
kidney cells [28], human pancreatic cells [29], and prostate
cancer cells [30]. However, there has been no such study
performed using colon cancer cells.
The microenvironment of tumors is often character-
ized by an insufficient amount of nutrients available for
rapid cell proliferation, leading to alteration of the
AMP/ATP ratio and activation of AMP-activated protein
kinase (AMPK), an energy-sensing kinase that regulates
cell metabolism. Similarly, energetic stress during cancer
metastasis is known to activate AMPK [31–33]. Al-
though AMPK has also been shown to be sensitive to
oxidative stress [34], its involvement in cancer metastasis
is somewhat dependent on the type of stimulus and oxi-
dative conditions. Lysophosphatidic acid-induced activa-
tion of AMPK enhances ovarian cancer cell migration
[35], whereas exogenous chemical-induced activation of
AMPK inhibits melanoma and colon cancer cell migration
[36–38]. Increased AMPK activity has been observed in
colon cancer cells in response to exogenous H2O2 [39].
However, it is unclear whether or not ROS-associated
AMPK activation is related to NOX1, which is highly
expressed in colon cancer cells compared to normal ad-
jacent tissues [40]. On the other hand, AMPK has been
reported to suppress phorbol ester-induced ROS produc-
tion [41], and AMPK deletion is associated with increased
NOX activity [42, 43]. Therefore, the precise regulatory
relationship between AMPK and NOX needs to be clearly
determined in order to develop a proper strategy to block
cancer invasion and metastasis.
In the current study, we investigated the regulatory
roles of NOX in MMP-7 expression and AMPK activity
by comparing invasive behaviors of HT29 and SW620colon cancer cells. To induce invasion, cells were treated
with 12-O-tetradecanoylphorbol-1,3-acetate (TPA), which
has been demonstrated to induce migration and in-
vasion in several human cancer cells via induction of
MMPs [44–46].
Results
MMP-7 expression is correlated with invasive phenotype
in TPA-treated HT29 colon cancer cells
To examine molecular changes, such as MMP expres-
sion, in invasive colon cancer cells, less metastatic HT29
cells and highly metastatic SW620 cells were compared.
Basal expression pattern of MMPs was similar in both
HT29 and SW620 cells, except for a much higher level
of MMP-7 expression in SW620 cells (Fig. 1a). Treat-
ment with TPA (tumor promoter) significantly induced
invasion of both HT29 and SW620 cells with a more
dramatic effect in SW620 cells (Fig. 1b). Invasion of the
cells also corresponded to the induction level of MMP-7
(Fig. 1c). In addition, silencing of MMP-7 expression
with siRNA (Fig. 1d) completely blocked TPA-induced
invasion of both HT29 and SW620 cells (Fig. 1e). Simi-
lar changes in invasion (Fig. 1f ) and MMP-7 expression
(Fig. 1g and Additional file 1: Figrue S1) were also ob-
served in TPA-treated Caco-2, a well-differentiated and
non-invasive colon cancer cell line, and HCT116, another
invasive colon cancer cell line.
Molecular switch from NOX1 to NOX2 combined with
NOX2-derived ROS production induces expression of
MMP-7 and invasion of TPA-treated colon cancer cells
High expression of NOX1 is observed during colon can-
cer, and ROS act as signaling molecules in migration
and invasion of cancer cells [15, 44]. Therefore, we next
examined whether or not TPA induces NOX-derived
production of ROS as well as invasive cell behavior. TPA
increased ROS production in both HT29 and SW620
cells in a time-dependent manner, reaching a maximum
level at 1 h that was maintained until 24 h (Fig. 2a). In
HT29 cells, TPA-induced ROS production was suppressed
by pretreatment with DPI and apocynin (NADPH oxidase
inhibitors) as well as antioxidant vitamin E (Vit. E) but not
celecoxib (COX-2 inhibitor) or antimycin A (mitochon-
dria inhibitor). Similarly, TPA-induced Matrigel invasion
was suppressed by DPI and Vit. E but not celecoxib or
antimycin A (Fig. 2b). These results indicate a significant
role for NADPH oxidase-derived ROS production in inva-
sion of HT29 cells.
We next examined which NOX isoform is responsible
for ROS production in colon cancer cells, which report-
edly express a high level of NOX1 and moderate level
of NOX2 [40, 47]. NOX isoforms were differentially ex-
pressed between less metastatic (HT29 and Caco2) and
highly metastatic (SW620 and HCT116) colon cancer
Fig. 1 TPA-induced increase in MMP-7 expression corresponds to invasive ability of colorectal cancer cells. a Total RNAs from untreated basal
HT29 and SW620 cells were analyzed for MMPs by qRT-PCR. The bar graph represents relative expression density of each MMP, and data values
are the mean ± SEM from three independent experiments. *P < 0.05 compared to HT29 cells. b HT29 and SW620 cells seeded in a Matrigel-coated
transwell were treated with TPA in serum-free media, and invaded cells were counted. The bar graphs represent the relative numbers of invaded
cells. *P < 0.05 compared to vehicle-treated control group. #P < 0.05 compared to TPA-treated HT29 cells. c HT29 and SW620 cells were treated
with TPA (12 ng/ml) for the indicated time, and extracted mRNAs and proteins were analyzed for induction of MMP-7 expression by qRT-PCR and
immunoblotting. *p < 0.05 compared to vehicle-treated control group of each cell line. d Efficiencies of MMP-7 siRNA as measured by Western
blotting in HT29 and SW620 cells. e In both HT29 and SW620 cells transfected with non-target (NT) and MMP-7 siRNAs, TPA-induced invasion was
measured as described in (b). *P< 0.05 compared to vehicle-treated control (Mock) group. #P< 0.05 compared to NT siRNA-treated cells. All measurements
were performed by three independent experiments. f, g TPA induced invasive phenotype change (f) in along with enhanced expression of MMP-7 (g) in
Caco-2 and HCT116 cells
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and NOX2 mRNA (Fig. 2c). In HT29 and Caco2 cells,
the basal level of NOX1 was highly expressed, and
treatment of the cells with TPA reduced the NOX1
mRNA copy number, whereas low level of basal NOX2
expression in the cells was dramatically increased by
TPA treatment. In SW620 and HCT116 cells, basal
NOX1 expression was trace level, which was further
decreased by TPA treatment, whereas basal NOX2 ex-
pression in SW620 and HCT116 cells was relatively
higher than that in HT29 and Caco2 cells, and TPA
treatment dramatically increased NOX2 mRNA copy
number. The two cell lines were different in produ-
cing ROS at the basal level without TPA, higher ROSgeneration in SW620 cells than in HT29 cells
(Fig. 2d). To determine which NOX isoform partici-
pates in TPA-induced ROS production and HT29 cell
invasion, we performed siRNA transfection. In both HT29
and SW620 cells, silencing of NOX2 but not NOX1 inhib-
ited basal NADPH oxidase activity (Fig. 2e). Moreover,
knockdown of genes using siRNAs specific to NOX2 and
its activator p67phox but not NOX1 significantly sup-
pressed TPA-induced expression of MMP-7 in HT29 cells
as well as in SW620 cells (Fig. 2f). In addition, even
though NOX1 was highly expressed in HT29 cells, silen-
cing of NOX1 did not inhibit TPA-induced ROS produc-
tion, as measured by fluorescent microscopy using DCF to
detect intracellular H2O2 (Fig. 2g) and NADPH oxidase
Fig. 2 NOX-2 derived ROS enhances MMP-7 expression and invasion of TPA-treated colon cancer cells. a Superoxide production in TPA (12 ng/
ml)-treated HT29 and SW620 cells was measured by chemiluminescence (CL) using lucigenin (400 μM). b HT29 cells were pretreated with Apo
(100 μM), DPI (10 μM), Cele (20 μM), ANT (10 μM), or Vit. E (50 μg/mL) for 1 h prior to TPA treatment for 1 h. Intracellular ROS level using DCF-DA
(upper panel) and invasion (lower panel) were determined by fluorescence microscopy and Matrigel invasion assay, respectively. The bar graph
represents quantitative data on ROS as measured by lucigenin chemiluminescence assay and invasion. Apo, apocynin; DPI, diphenyleneiodonium;
Cele, celecoxib; ANT, antimycin A. *P < 0.05 compared to control group. #P < 0.05 compared to TPA-treated cells. c Basal mRNA expression of
NADPH oxidase components was measured by qRT-PCR in HT-29 and SW620 cells. The data represents mean ± SEM from three independent
experiments. *P < 0.05 compared to HT29 cells. d Basal superoxide production normalized by cellular protein content was compared between
HT29 and SW620 cells. *P < 0.05 compared to HT29 cells. e-h Cells were transfected with siRNA specific to NT, NOX1, NOX2, or p67phox. Basal
NADPH oxidase activity (e) was measured by using lucigenin chemiluminescence. *P < 0.05 compared to NT-treated group. TPA-induced
expression of NOX1, NOX2, and MMP-7 (f), production of ROS (g, upper panel of each cell line), and invasion (g, lower panel of each cell line)
were examined in both HT29 and SW620 cells. The bar graph represents the NADPH oxidase activity measured by lucigenin chemiluminescence
using protein extracts after transfection with siRNA (h) and number of invaded cells (i). *P < 0.05 compared to vehicle-treated control group.
#P < 0.05 compared to TPA-treated cells
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was also observed in SW620 cells. However, siRNAs
specific to NOX2 and p67phox significantly blocked
TPA-induced ROS production as well as cell invasion
(Fig. 2g). Further, TPA-induced invasion was significantly
suppressed by NOX2 and p67phox siRNAs but not
NOX1 siRNA in both HT29 and SW620 cells (Fig. 2i).
NOX2-derived ROS regulates NOX1, NOX2, and MMP-7
expression through the MAPK pathway
HT29 cells expressed all components required for acti-
vation of NADPH oxidase, the catalytic core subunits
p22phox, NOX1, and NOX2, and the regulatory sub-
units NOXO1, NOXA1, p47phox, p67phox, and Rac1
(Fig. 3a). Treatment of HT29 cells with TPA suppressed
expression of NOX1 with significant changes starting atFig. 3 Expression of NOX2 and its regulator subunits, p47phox and p67-ph
HT29 cells treated with TPA (12 ng/ml) for the indicated time periods were
and Western blotting (c). d Protein extracts from HT29 cells treated with D
anti-NOX2, p47phox, and p67-phox antibodies. β-Actin was used for equal loa
time, and Western blotting was performed for detection of MMP-7, NOX2, p4
experiments, and bar graphs indicate the mean ± SEM of relative densities of
#P < 0.05 compared to TPA-treated group3 h (Fig. 3b and c). In contrast to NOX1, TPA increased
mRNA expression levels of NOX2, p47phox, and
p67phox in a time-dependent manner, and the degree of
induction was strongest for p67phox (Fig. 3b and c). The
TPA-induced increase in NOX2 accompanying with re-
duction of NOX1 protein expression was also observed in
Caco2 cells (Additional file 2: Figure S2). The increased
expression of NOX2 and its regulators was significantly
suppressed by DPI as well as antioxidants (Vit. C and Vit.
E) starting from 1 h until 6 h, whereas ROS suppressed
NOX1 expression only at 6 h (Fig. 3d). These results indi-
cate that NOX2-derived ROS increase expression of
NOX2 and its regulators, p47phox and p67phox, as well
as reduce NOX1 expression. To further confirm, cells dir-
ectly exposed to exogenous ROS were examined for in-
duction of these same genes. Application of exogenousox, is regulated by NOX2-derived ROS in TPA-treated HT29 cells. a-b
analyzed for gene expression by conventional PCR (a), qRT-PCR (b),
PI, NAC, and Vit. E in the presence of TPA were immunoblotted with
ding. e HT29 cells were stimulated with H2O2 (5 μM) for the indicated
7phox, and p67-phox. Bands are representative of three independent
the gene products. *P < 0.05 compared to vehicle-treated control group.
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p67phox, and p47phox as well as MMP-7 in a time-
dependent manner (Fig. 3e). In contrast, reduced NOX1
expression was observed from 3 h after H2O2 treatment.
We next investigated the involvement of MAPKs as
downstream signaling molecules for gene induction.
TPA increased phosphorylation of MAPKs, ERK, p38,
and JNK starting at 5 min continuously up to 24 h
(Fig. 4a). PD98059 and SP600125 (ERK and JNK inhibi-
tors, respectively) did not suppress TPA-induced expres-
sion of NOX2 or its regulators, whereas SB203580 (p38
inhibitor) did show suppressive effects similar to those
of DPI (Fig. 4b). In contrast, MMP-7 gene expression
was suppressed by PD98059, SP600125, SB203580, andFig. 4 Expression of NOX2 and its regulators is mediated through p38 and
and NF-κB. Protein extracts from cells treated with TPA (12 ng/ml) alone or
MAPKs (a), expression of NOX2, its regulators, and MMP-7 (b and d), and n
SP, SB, and SR represent 10 μM PD98059, SP600125, SB203580, and SR1130
densities of protein expression. e The luciferase reporter plasmid containing
and reporter activity was assessed following incubation of transfected cells
treatment. Values are the mean ± SEM from three independent experiment
compared to TPA-treated groupDPI (Fig. 4b). In addition, TPA activated the transcrip-
tion factors NF-κB, c-Fos and c-Jun in HT29 cells
(Fig. 4c), although their involvement in gene regulation
varied. TPA-induced MMP-7 expression was suppressed
by SR11302 and PDTC (AP-1 and NF-κB inhibitors, re-
spectively), whereas NOX2, p47phox, and p67phox ex-
pression was inhibited by PDTC but not SR11302
(Fig. 4d). Further, in reporter gene analysis using a re-
porter plasmid containing human NF-κB (NF-κB-Luc)
or AP-1 (AP-1-Luc) response element, TPA-enhanced
AP-1-Luc reporter activity was significantly suppressed
by SB203580, PD98059, and SP600125, whereas TPA-
enhanced NF-κB-Luc reporter activity was inhibited only
by SB203580 (Fig. 4e).NF-κB, whereas MMP-7 expression is mediated through MAPKs, AP-1,
TPA with various inhibitors were examined for phosphorylation of
uclear translocation of the transcription factors NF-κB and AP-1 (c). PD,
2, respectively. The bar graphs indicate the mean ± SEM of relative
human NF-κB or AP-1 response element was transiently transfected,
with TPA for 3 h. Various inhibitors were pretreated 1 h before TPA
s. *P < 0.05 compared to vehicle-treated control group. #P < 0.05
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inversely regulated by ROS production in HT29 colon
cancer cells
We also investigated AMPK activity in response to ROS
during colon cancer cell invasion. Under serum-starved
conditions, AMPK phosphorylation was higher in HT29
cells than in SW620 cells (Fig. 5a). TPA treatment inhib-
ited AMPK phosphorylation in HT-29 cells (Fig. 5b)
starting from 5 min after treatment, which is in line with
increased ROS production (Fig. 2a and g) and subse-
quent invasion. In SW620 cells, reduction of AMPK
phosphorylation by TPA occurred in a similar pattern
compared to that in HT29 cells. In addition, pretreat-
ment with AICAR and D942 (AMPK activators) signifi-
cantly blocked TPA-induced ROS production and cell
invasion (Fig. 5c and d). On the other hand, treatment
with AICAR or D942 alone without TPA did not cause
any change in ROS production or cell invasion.
We next investigated any link between reduced AMPK
phosphorylation and NOX2-derived ROS production.Fig. 5 Reduced AMPK phosphorylation corresponds to increased ROS prod
AMPK activators. a Basal AMPK phosphorylation was compared between H
phospho-AMPK/AMPK from three independent experiments. *P < 0.05 com
were examined for phospho-AMPK by Western blotting. c HT29 cells were
the presence or absence of TPA for 1 h. Cells were then examined for ROS
invasion (lower panel). d Superoxide anion production was measured by lu
counting cells on the bottom of the insert. The bar graph represents the m
to vehicle-treated control group. #P < 0.05 compared to TPA-treated cellsTPA-induced reduction of AMPK phosphorylation was
blocked by DPI and antioxidants (NAC and Vit. E)
(Fig. 6a). Reduction of AMPK phosphorylation was also
blocked by pretreatment with siRNAs specific to NOX2
and p67phox, which was commonly observed in both
HT29 and SW620 cells (Fig. 6b). Based on these results,
AMPK phosphorylation was apparently inhibited by
TPA-induced ROS production, which contradicts previ-
ous reports that ROS increases phosphorylation of
AMPK [48, 49]. To determine whether or not the ROS
level can explain this discrepancy, we investigated AMPK
activity in response to different concentrations of
ROS. HT29 cells exposed to different concentrations
of exogenous H2O2 responded differently, showing a
U-shape response curve for AMPK phosphorylation.
Specifically, AMPK phosphorylation decreased in the
presence of 10 μM H2O2 and increased at concentrations
over 10 μM H2O2 (Fig. 6c). On the contrary, NOX2 and
MMP-7 expression showed opposite patterns (Fig. 6c).
Treatment with 1 to 500 μM H2O2 did not affect celluction and invasion of TPA-treated HT29 cells, which is reversed by
T29 and SW620 cells. The bar graph represents the mean ± SEM of
pared to HT29 cells. b Protein extracts from TPA-treated HT29 cells
treated with AMPK activators, AICAR (250 μM) and D942 (10 μM), in
production (upper panel) by DCF fluorescence microscopy and
cigenin chemiluminescence assay, and invasion was quantitated by
ean ± SEM from three independent experiments. *P < 0.05 compared
Fig. 6 TPA-induced reduction of AMPK phosphorylation is dependent on NOX2-derived ROS production. a Protein extracts from HT29 cells
pretreated with DPI (10 μM), NAC (10 μM), and Vit. E (50 μg/mL) for 1 h prior to treatment with TPA (1 h) were examined for phospho-AMPK/
AMPK levels. b HT29 and SW620 cells transfected with siRNA specific to NT, NOX2, or p67phox were treated with TPA and analyzed for expression
of phospho-AMPK. c HT29 cells were treated with exogenous H2O2 at the indicated concentrations for 1 h, and cell extracts were examined for
levels of phospho-AMPK/AMPK, NOX1, NOX2, and MMP-7. d HT29 cells treated with H2O2 were analyzed for cellular ATP level using a Mitochondrial
ToxGlo™ assay kit. Cytotoxicity was measured at the same time using the kit. (e, f) HT29 cells treated with AICAR or D942 in the presence or absence
of TPA were analyzed for mRNA (e) or protein (f) expression. The bar and line graphs show the mean ± SEM from three independent experiments.
*p < 0.05 compared to control, #p < 0.05 compared to TPA-treated group
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AMPK activators suppressed TPA-induced expression of
NOX2, p47phox, p67phox, and MMP-7 (Fig. 6e and f),
and the effect was similar to that of DPI (Fig. 6f). How-
ever, treatment of cells with AMPK activators in the ab-
sence of TPA did not affect mRNA (Fig. 6e) or protein
(Fig. 6f) expression of NOX2 and MMP-7, which is simi-
lar to the case of basal ROS production and invasion in
HT29 cells (Fig. 5c and d).
Discussion
MMP-7 is unique in that it is predominantly expressed
in epithelial cells as opposed to other MMPs, which are
mostly expressed in the stroma [50, 51]. Overexpression
of MMP-7 in human squamous cell carcinomas, in par-
ticular colon cancer cells, shows a strong positive correl-
ation with metastatic potential of cancer cells [52–54].In the current study, we observed that MMP-7 was dif-
ferentially expressed in colon cancer cell lines, HT29,
Caco2, SW620, and HCT 116, having different invasive
potentials. The TPA-induced transition from less (HT29
and Caco2 cells) to highly metastatic (SW620 and
HCT116 cells) was associated with enhanced MMP-7
expression, which was dependent on the molecular
switch from NOX1 to NOX2.
MMP gene expression is not constitutive but is rather
regulated by various cytokines via activation of intracel-
lular signaling pathways [55]. In our current study,
complete blockage of TPA-induced invasion of both
HT29 and SW620 cells was observed in the case of ei-
ther MMP-7 silencing or pretreatment with DPI and
Apo (NADPH oxidase inhibitors), indicating a regulatory
role for NADPH oxidase in MMP-7 induction as well as
cancer cell invasion. It has been reported that MMP-7
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[15]. In this study, we clearly observed that the source of
ROS governing MMP-7 expression in colon cancer cells
was NADPH oxidase. In addition, the current results of
NADPH oxidase activity measurement showing that
NOX1 siRNA had no effect on TPA-induced ROS gener-
ation demonstrate that TPA-induced ROS was inde-
pendent of NOX1 despite high NOX1 levels in HT29
cells. A previous study by Sadok et al., [56] showed that
NOX1 silencing using siRNA decreases superoxide pro-
duction in HT29-D4 cells. This contradictory result
could be attributed to a difference in the type of stimu-
lus given to cells, because in the previous study, cells
were induced to be in migratory phase by being placed
on collagen-I which activates integrin signaling. How-
ever, further study is required for the underlying mech-
anism to be solved. Our current results also demonstrate
that treatment of HT29 cells with TPA reduced NOX1
expression to a level similar to that in untreated SW620
cells. These results are somewhat in line with previous
reports that NOX1 is constitutively expressed in the
colon epithelium to a similar degree as in differentiated
colon cancer cells [57], and increased NOX1 expression
suppresses proliferation of cancer cells, driving them
into a differentiated cancer state [58]. An important role
of NOX1 in tumorigenesis has been suggested based on
several findings. Induction of NOX1 mRNA transcrip-
tion has been observed in non-cancerous cells such as
smooth-muscle cells, and fibroblasts by stimulation with
platelet-derived growth factor or epidermal growth fac-
tor [59, 60]. It is also reported that K-Ras mutation corre-
lates with increased NOX1 mRNA expression and colon
tumor phenotype [61]. However, based on human tumor
tissue array findings of diminished NOX1 expression at a
more advanced tumor stage [58], it is suggested that
tumor-promoting action of NOX1 seems to be an early
event [62]. Our current results showing that NOX1 ex-
pression is diminished as colon cancer cells undergo inva-
sive phenotype change also support such suggestion.
In contrast to NOX1, NOX2 expression was elevated
and accompanied by enhanced MMP-7 expression in
TPA-treated HT29 cells, which was similar to that in
basal SW620 cells. In addition, NOX2 siRNA inhibited
basal NADPH oxidase activity, TPA-induced ROS pro-
duction, MMP-7 expression, and cell invasion, indicating
that NOX2 plays a critical role in induction of MMP-7
expression in invasive cancer cells. These results further
indicate that switch from NOX1 to NOX2 induces colon
cancer cells to be highly invasive. In support of this,
ROS have been reported to play signaling roles in nor-
mal cells such as cardiomyocytes and keratinocytes for
pro-survival [63] or MMP-9 induction [64]. Likewise,
the results of the current study demonstrate that MMP-
7 expression was accompanied by activation of MAPKsas well as the transcription factors NF-κB and AP-1. At
the same time, NOX2-activated ROS constituted an
autoregulatory loop for expression of NOX2 and its reg-
ulators, p47phox and p67phox in TPA-treated colon
cancer cells. This is similar to the previous finding that
expression of phagocytic NADPH oxidase subunits is
up-regulated by stimulus-induced ROS in a positive
feedback mechanism [65].
AMPK activation in colon cancer cells has been re-
ported to suppress the expression of genes associated
with invasion and metastasis, including integrin β1 and
cyclooxygenase-2 [37, 38]. In the current study, we ob-
served for the first time that AMPK activity was in-
versely linked to MMP-7 expression in colon cancer
cells. At a basal level, low MMP-7 expression and high
AMPK phosphorylation were observed in less invasive
HT29 cells, whereas low AMPK phosphorylation and
high MMP-7 expression were observed in SW620 cells.
Such an inverse relationship between AMPK activity and
MMP-7 expression was further confirmed based on our
observations that TPA-induced MMP-7 expression was
accompanied by reduced AMPK phosphorylation and
that AMPK activator blocked TPA-induced MMP-7 ex-
pression. In addition, a low concentration (5 μM) of H2O2
suppressed AMPK phosphorylation, which was prevented
by DPI or antioxidants as well as siRNAs specific to
NOX2 and p67phox. This result indicates that AMPK
phosphorylation was suppressed by NOX2-activated ROS
production in TPA-treated HT29 cells. Gene expression
in response to NOX2-activated ROS production in HT29
cells was very similar to that in 5 μM H2O2-treated cells.
Further, we observed for the first time that AMPK phos-
phorylation was differentially regulated according to ROS
concentration, showing a U-shape dose–response curve
associated with ATP production in HT29 cells. Low con-
centration of H2O2 up to 10 μM resulted in increased
ATP production and a corresponding decrease in AMPK
phosphorylation, which was reversed at above 10 μM
H2O2. Our current study, which used a full range of H2O2
concentrations, actually supports previous findings
showing that ROS activates AMPK [34, 66, 67]. How-
ever, in contrast to previous reports of a direct rela-
tionship between AMPK activation and mitochondrial
ROS production in cancer cells [32], our results suggest
that plasma membrane NOX2-derived ROS production
deactivates AMPK. Despite our results that AMPK phos-
phorylation and ATP production are exactly matched in
response to H2O2 treatment, the underlying mechanism
must be elucidated.
AMPK phosphorylation was inversely correlated with
the expression level of NOX2, indicating that there is a
feedback loop between NOX and AMPK. However, AMPK
activators alone in the absence of TPA did not suppress
basal ROS production or NOX2 gene expression,
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ROS generation is a prerequisite of AMPK suppres-
sion. Further, our results suggest that deactivated
AMPK did not exert any inhibitory effect on stimulus-
induced NOX2 expression and thus MMP-7 gene induc-
tion over time.
Conclusions
MMP-7 overexpression drives colon cancer cells into an
highly invasive phenotype through molecular switch
from NOX1 to NOX2. NOX2-derived ROS production
reduces NOX1 gene expression and enhances expression
of NOX2 and MMP-7 by deactivating AMPK, which
otherwise exerts an inhibitory effect against stimulus-
induced autoregulation of ROS and NOX2 gene expres-
sion. The study provides a comprehensive molecular
mechanism of the invasive phenotype in colon cancer
cells (Fig. 7).Fig. 7 Molecular switch from NOX1 to NOX2 induces invasive phenotype c
ERK, and JNK with deactivation of AMPK. P38 activates NF-κB, which induce
activate AP-1, which up-regulates MMP-7 gene expression in cooperation wMethods
Materials
All reagents were purchased from Sigma-Aldrich (St.
Louis, MO, USA), if not specified. RPMI1640, MEM, fetal
bovine serum (FBS), penicillin/streptomycin, and trizol re-
agent were purchased from Invitrogen Life Technologies
(Carlsbad, CA, USA). Antibody of Lamin B, I-κB-α rabbit
polyclonal antibody, β-actin mouse monoclonal antibody,
NF-κB p65 rabbit polyclonal antibody, phospho-ERK anti-
body, MMP-7 goat polyclonal antibody, p67phox goat
polyclonal antibody, NOX1 rabbit polyclonal antibody,
NOX2 goat polyclonal antibody, celecoxib were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Phospho-p38 MAPK antibody, ERK antibody, p38 MAPK
antibody, phospho-AMPK-α, AMPK-α, phospho-JNK,
JNK, C-Jun, phospho I-κB, and PD98059 were purchased
from Cell Signaling Technology, Inc. (Boston, MA, USA).
Matrigel was obtained from BD Biosciences (Bedford,hange in colon cancer cells. NOX2-derived ROS activates MAPKs, p38,
s NOX2, p47phox, and p67phox. At the same time, p38, ERK, and JNK
ith NF-κB
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Inc. (Walkersville, MD, USA). SR11302 was purchased
from Tocris Bioscience (Tocris House, Bristol, BS110QL,
UK). D942 was purchased from Calbiochem (10394,
Pacific Center Ct, CA, USA).
Cell culture
Human colorectal cancer cells HT29 and SW620 were
obtained from the American Type Culture Collection
(Manassas, VA, USA). HT29 cells and SW620 cells were
cultured in RPMI 1640 and DMEM high glucose media,
respectively, containing 10 % FBS, 100 IU/ml of penicillin,
and 100 μg/ml of streptomycin. Cells were maintained at
37 °C in 5 % CO2. After reaching 70 % confluence, cells
were sub-cultured by splitting at 1:3 ratios.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was isolated using Trizol reagent following
the manufacturer’s instructions. The extracted RNA was
reverse-transcribed to cDNA using a GoScript Reverse
Transcription system (#A5001, Promega Corporation,
WI, USA). cDNA was amplified in the presence of 0.5 U
of Taq DNA polymerase (Takara, Japan) using specific
primers on Corbett Rotor-Gene (Corbett Life Science).
Quantitative analysis of mRNA was done using a Quan-
tiTect SYBR Green PCR kit (Qiagen). Primers for MMP-
2, MMP-9, TIMP-1, TIMP-2, and GAPDH were supplied
by Qiagen, and the other primer sequences used were
MMP-7 (sense 5’-GGAGATGCTCACTTCGATGA-3’ and
antisense 5’-ATACCCAAAGAATGGCCAAG -3’), NOX1
(sense 5′-GTTTTACCGCTCCCAGCAGA −3′ and anti-
sense 5′-GGATGCCATTCCAGGAGAGA-3′), NOX2
(sense 5′-CCTAAGATAGCGGTTGATGG-3′ and anti-
sense 5′-GACTTGAGAATGGATGCGAA -3′), p47phox
(sense 5′-GCTGGTGGGTCATCAGGAAA-3′ and anti-
sense 5′-GCCCTGACTTTTGCAGGTAC −3′), and
p67phox (sense 5′-CCTGCAACTACCTTGAACCA −3′
and antisense 5′- GGACTGCGGAGAGCTTTCC-3′).
Matrigel invasion assay
Matrigel invasion assay was performed as described pre-
viously by Park et al. [46]. Briefly, inner and outer parts
of the Transwell insert (BD Falcon, Franklin Lakes,
USA) were coated with Matrigel (0.5 mg/ml) and colla-
gen (1 mg/ml) respectively. TPA was added to all wells
except the control well, after which 100 μl of cell sus-
pension (5x105 cells/ml) in the presence or absence of
inhibitors and antioxidants in serum-free media was
added to the inner part of the transwell. After 24 h, in-
vaded cells were fixed and stained with methanol and
H&E separately. The number of invaded cells per field
was captured using a microscope fitted with a camera at
200x magnification.Subcellular fractionation and Western blot analysis
For subcellular fractionation, HT29 cells cultured in a
100-mm dish were serum-starved overnight and stimu-
lated with TPA (0 to 60 min). Cells were harvested with
100 μl of subcellular fractionation buffer (SF) consisting
of 250 mM sucrose, 20 mM HEPES (pH 7.4), 10 mM
KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM
Dithiothreitol, 1x protease, and phosphatase inhibitor
cocktail. Cells were passed through a 30 G needle 30–35
times on ice. The cell suspension was centrifuged at
700 g for 10 min at 4 °C. The supernatant was collected
in a glass tube and centrifuged at 100,000 rpm (Sorvall
RC M120 EX ultracentrifuge) for 1 h at 4 °C. After col-
lecting supernatant containing the cytosolic fraction,
the pellet was suspended in 60 μl of SF. The suspen-
sion was sonicated for 30 s four times at the highest
setting with a 30-s break in each cycle. The suspension
was centrifuged again at 100,000 rpm for 1 h at 4 °C,
and supernatant containing the membrane fraction was
collected.
Cytoplasmic and nuclear proteins were extracted using
a NE-PER nuclear and cytoplasmic extraction reagent kit
(#78833, Thermo Scientific, Rockford, USA) according to
the manufacturer’s instructions. For isolation of total pro-
teins, cells were lysed in radioimmunoprecipitation assay
buffer (RIPA) containing protease and phosphatase inhibi-
tor cocktail (Thermo Scientific). Cells were centrifuged at
12,000 rpm for 10 min, and supernatant containing sol-
uble proteins was collected.
Protein concentration was determined using a BCA
protein assay kit (Thermo Scientific). Equal quantities of
proteins were resolved by 10-14 % SDS-PAGE, transferred
onto a nitrocellulose membrane, and blocked using 5 %
skim milk in TBS-Tween 20 (TBST) for 1 h. In the case
of phospho-protein, membranes were blocked in 5 %
bovine serum albumin in TBST for 1 h. Membranes
were incubated with specific primary antibodies over-
night at 4 °C, followed by incubation with horseradish
peroxidase-conjugated secondary antibody for 1 h at
room temperature. The immunoreactive proteins were
detected using an enhanced chemiluminescent reagent
(Thermo Scientific) system on a luminescent image
analyzer, LAS-4000 mini (Fujifilm, Tokyo, Japan). In
each step after blocking, membranes were washed with
TBST.
Transfection of colon cancer cells with siRNA
HT29 and SW620 cells were transiently transfected
using siRNAs (NOX1, NOX2, p67phox, and MMP-7) in
opti-MEM I medium containing Dharmacon reagent
(# T-2004-01, Thermo Scientific) as previously described
by Regmi et al. [68]. The transfected cells were then sub-
jected to invasion assay, ROS measurement, and Western
blot analysis.
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Superoxide anion production was measured by lucigenin
chemiluminescence assay as described by Regmi et al.
[68] with some modifications. Cells were seeded in
96-well white opaque plates (1×105 cells/well). After
overnight incubation, cells were pretreated with drugs
in serum-free media prior to treatment with or without
TPA (12 ng/ml) for the indicated time. Chemilumines-
cence was then measured using lucigenin (400 μM) with a
Fluostar Optima microplate reader.
Intracellular ROS measurement
Cellular ROS was measured using a cell-permeable fluore-
genic probe, 2’,7’-dichlorofluorescein diacetate (DCF-DA).
Overnight serum-starved HT-29 cells (1×105 cells/cm2)
were treated with or without TPA for the specific time
points. After washing with PBS, cells were incubated with
10 μM DCF-DA at 37 °C for 30 min. The cells were
washed again with PBS, and images were captured using a
digital camera (TE2000-U, Nikon, Japan) with a blue filter
(B-2E/C, FITC) at 200x magnification.
mRNA copy number determination
The number of transcripts of NOX1 and NOX2 was de-
termined as previously described methods [68, 69]. Briefly,
human NOX1 and Nox2 cDNAs (Invitrogen) were cloned
into pcDNA5/FRT/TO vector (Invitrogen). The following
equation was used to calculate the copy number:
DNA copiesð Þ ¼ ½6:02  1023 copies=moleð Þ
 DNA concentration gð Þ
 DNA length bpð Þ  660 g=mol=bpð Þ½ :
To generate standard curve of NOX1 and NOX2, each
plasmid were serially diluted 10 folds ranging from 101
to 105 copy numbers. cDNA synthesized from isolated
total RNA of cells in the absence or presence of TPA for
24 h were subjected to real-time PCR using QuantiTect
SYBER Green PCR kit (Qiagen) with NOX1 and Nox2
primer sequences. Copy number of NOX1 and Nox2 in
HT29, Caco-2, SW620, HCT116 was calculated from
the standard curve.
NADPH Oxidase activity assay
The NADPH oxidase activity assay was performed by
modifying the method described by [70]. Briefly, cells
were transfected with siRNAs of non-specific, NOX1
and NOX2. The cells were harvested in Krebs-HEPES
buffer (pH 7.4) containing protease and phosphatase
inhibitor cocktail (Thermo Scientific), homogenized with
Dounce homogenizer, and centrifuged at 10,000 g for
15 min. After determining protein concentration using a
BCA protein assay kit (Thermo Scientific), equal amount
of proteins was transferred to the 96 well (white plate)with 10 μM lucigenin prepared in the same buffer and
incubated at 37 °C for 10 min. Then, 100 μM NADPH
was added to each wells with or without TPA. After
5 min incubation at 37 °C, the chemiluminescence was
measured with a Fluostar Optima microplate reader.Measurement of ATP
Mitochondrial function was assessed using Mitochon-
drial ToxGlo™ Assay (#G8000, Promega). Briefly, HT-29
cells (10,000 cells/well) were seeded in a 96-well opaque
white-walled flat bottom plate (Falcon). After 24 h of
incubation at 37 °C, cells were washed with PBS, and
serum-free galactose-containing media (glucose-free)
was added to each well. Cells were treated with different
concentrations of H2O2 (1 to 500 μM) or TPA (12 ng/ml)
for 1 h. Cytotoxicity was first assessed using fluorogenic
peptide substrate (bis-AAF-R110). Fluorescence was mea-
sured using a Fluostar optima microplate reader (BMG
Labtech GmbH, Offenburg, Germany) with excitation at
485 nm and emission at 520 nm. Next, cells were lysed by
addition of ATP detection reagent, and luminescence was
measured using a Fluostar optima microplate reader
following the manufacturer’s instructions from the Mito-
chondrial ToxGlo™ assay kit. The amount of ATP is dir-
ectly proportional to the luminescence signal.Reporter plasmid transfection and Luciferase activity
measurement
Transactivation of NF-κB and AP-1 was studied using
the dual Luciferase reporter assay system (Promega,
Madison, WI) following the manufacturer’s instructions.
Briefly, HT29 cells were seeded in a 24-well plate at a
density of 7×104 cells/well in antibiotic-free media
containing 10 % FBS. The next day, cells were co-
transfected with NF-κB (Affymetrix) or AP-1 (Panomics)
reporter vectors along with control vector (pRL-TK)
using Lipofectamine 2000. The transfection media was
replaced with RPMI 1640 containing 10 % FBS after 18 h,
and the cells were further allowed to grow for another
24 h. Then, the transfected cells were treated with MAPK
inhibitors for 1 h prior to treatment with TPA for another
3 h. The lysates were used for the assay.Statistical analysis
All data are the mean of three independent experi-
ments. Error bar represents SEM Statistical signifi-
cance was determined using Student’s t-test or one-
way ANOVA followed by the Student-Newman-Keuls
comparison method for calculation of differences between
groups (GraphPad Prism 5.0 software, San Diego, CA,
USA). Values of P < 0.05 were considered statistically
significant.
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Additional file 1: Figure S1. Differentially expressed MMP-7 in colon
cancer cell lines having different invasive potentials was increased by
TPA. A The mRNA level of MMP-7 and MMP-9 in HT29, Caco2, SW620,
and HCT116 cells was measured by qRT-PCR. *P < 0.05 compared to HT29
or Caco2 cells. B MMP-7 protein expressions in TPA-treated HT29, Caco2,
SW620, and HCT116 cells were analyzed by Western blot method. The
bar graphs indicate the mean ± SEM of relative densities of MMP-7
protein expression. *P < 0.05 compared to vehicle-treated control group.
Additional file 2: Figure S2. TPA induces decrease in NOX1 and
increase in NOX2 in Caco2 cells. Proteins were extracted from Caco2 cells
treated with TPA for the indicated time period, and analyzed by Western
blot. The bar graphs indicate the mean ± SEM of relative densities of
NOX1 and NOX2 protein expressions. *P < 0.05 compared to vehicle-treated
control group.
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